A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : CaP

Search Conditions:
Search Keyword : CaP
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 5 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: CaP
Appearance Frequency: 1347 time(s)
Long forms: 133

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
calcium phosphate
(988 times)
Biomedical Engineering
(378 times)
HA (90 times)
CaOx (58 times)
SBF (58 times)
1979 Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine.
carcinoma of the prostate
(81 times)
Urology
(31 times)
PSA (18 times)
BPH (16 times)
TURP (5 times)
1979 Cancer of the prostate: early diagnosis by zinc and hormone analysis?
cancer of the prostate
(46 times)
Urology
(22 times)
PSA (20 times)
BPH (13 times)
SAP (4 times)
1987 Serum prolactin assays have no prognostic value in treatment of prostatic cancer by orchidectomy or estrogens.
calponin
(20 times)
Biochemistry
(6 times)
CaD (7 times)
MLCK (2 times)
PKC (2 times)
1994 The regulatory role of myosin light chain kinase as an actin-binding protein.
calcium phosphate ceramic
(18 times)
Dentistry
(5 times)
BCP (2 times)
BG (2 times)
HA (2 times)
1999 Biological activities of sustained polymyxin B release from calcium phosphate biomaterial prepared by dynamic compaction: an in vitro study.
organ-confined prostate cancer
(15 times)
Neoplasms
(5 times)
AR (3 times)
PSA (3 times)
RP (3 times)
2000 Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.
calcium propionate
(13 times)
Nutritional Sciences
(5 times)
BW (2 times)
FA (2 times)
5CaP (1 time)
2005 Environmental factors and weak organic acid interactions have differential effects on control of growth and ochratoxin A production by Penicillium verrucosum isolates in bread.
caudal primary
(10 times)
Biology
(5 times)
PMNs (3 times)
syn4 (2 times)
AMO (1 time)
1997 Expression of c-ret in the zebrafish embryo: potential roles in motoneuronal development.
calcium pectinate
(7 times)
Carbohydrates
(2 times)
SEM (2 times)
5-ASA (1 time)
5-FU (1 time)
1993 In vitro evaluation of calcium pectinate: a potential colon-specific drug delivery carrier.
10  calcium phosphate co-precipitates
(5 times)
Pharmacology
(3 times)
DOTAP (1 time)
GAGs (1 time)
GAM (1 time)
2005 A new technique with calcium phosphate precipitate enhances efficiency of in vivo plasmid DNA gene transfer.
11  calcium-phosphate product
(5 times)
Nephrology
(2 times)
PTH (2 times)
AKI (1 time)
AVF (1 time)
2006 Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study.
12  Ca phosphate
(4 times)
Urolithiasis
(2 times)
AGN (2 times)
CaOx (2 times)
polyP (2 times)
2003 An effective and better strategy for reducing body burden of radiostrontium.
13  calcium phosphate ormoglasses
(3 times)
Biomedical Engineering
(2 times)
PLA (2 times)
2016 The proangiogenic potential of a novel calcium releasing biomaterial: Impact on cell recruitment.
14  current prostate cancer
(3 times)
Neoplasms
(2 times)
EpCAM (1 time)
KD (1 time)
PSA (1 time)
2000 Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping.
15  calcium orthophosphate
(2 times)
Biomedical Engineering
(1 time)
HA (2 times)
ACP (1 time)
MBG (1 time)
2002 Calcium phosphate thin film processing by pulsed laser deposition and in situ assisted ultraviolet pulsed laser deposition.
16  calcium phosphate bone cement
(2 times)
Anti-Bacterial Agents
(1 time)
AR (1 time)
BFs (1 time)
FE (1 time)
2005 Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
17  calcium phosphate substrate
(2 times)
Biomedical Engineering
(1 time)
WJSCs (1 time)
2017 Harnessing Wharton's jelly stem cell differentiation into bone-like nodule on calcium phosphate substrate without osteoinductive factors.
18  cancer of prostate
(2 times)
General Surgery
(1 time)
BPH (1 time)
ERG (1 time)
F/T (1 time)
2004 [Association of polymorphisms in testosterone 5-alpha-reductase II genotype and prognosis factors of prostate cancer].
19  cancer prostate
(2 times)
Neoplasms
(1 time)
ASR (1 time)
CIR (1 time)
KCR (1 time)
2009 Incidence and trends of prostate cancer in Karachi South, 1995-2002.
20  castration-recurrent prostate cancer
(2 times)
Urology
(2 times)
DHEA (1 time)
DHT (1 time)
HGPIN (1 time)
2011 5alpha-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.
21  caudal primary motoneuron
(2 times)
Biology
(1 time)
insm1a (1 time)
Isl-1 (1 time)
MiP (1 time)
1995 Molecular heterogeneity among primary motoneurons and within myotomes revealed by the differential mRNA expression of novel islet-1 homologs in embryonic zebrafish.
22  CDC prostate cancer
(2 times)
Neoplasms
(2 times)
miRs (1 time)
OPG (1 time)
2007 Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
23  collagen-calcium phosphate
(2 times)
Nanotechnology
(1 time)
BSA (1 time)
EDX (1 time)
FTIR-ATR (1 time)
2017 Fabrication of Hydroxyapatite Nanofiber via Electrospinning as a Carrier for Protein.
24  nano-calcium phosphate
(2 times)
General Surgery
(1 time)
BAF (1 time)
BIC (1 time)
BMSCs (1 time)
2010 Preparing nano-calcium phosphate particles via a biologically friendly pathway.
25  C adenocarcinoma of the prostate
(1 time)
Medicine
(1 time)
GnRH (1 time)
PSA (1 time)
TRUS (1 time)
1993 Neoadjuvant hormonal therapy in stage C adenocarcinoma of the prostate.
26  Ca and P
(1 time)
Veterinary Medicine
(1 time)
Std CaP (1 time)
TM (1 time)
2013 Effect of dietary calcium and phosphorus levels on the total tract digestibility of innate and supplemental organic and inorganic microminerals in a corn-soybean meal based diet of grower pigs.
27  Ca and P formation
(1 time)
Biomedical Engineering
(1 time)
AH (1 time)
CP (1 time)
SBF (1 time)
2009 An in vitro comparison of possibly bioactive titanium implant surfaces.
28  Ca++-dependent action potentials
(1 time)
Pharmacology
(1 time)
RMP (1 time)
1983 Action of tetrodotoxin and verapamil on cardiac Purkinje fiber action potentials in a sodium-free, calcium-rich medium.
29  calcium and phosphorus abnormalities associated with metastatic prostate carcinoma
(1 time)
Urology
(1 time)
ANM (1 time)
Ca (1 time)
PTH (1 time)
1986 Human prostate carcinoma causes hypercalcemia in athymic nude mice and produces a factor with parathyroid hormone-like bioactivity.
30  calcium dihydrogen phosphate
(1 time)
Environmental Health
(1 time)
SEM/EDX (1 time)
XRD (1 time)
2017 Stabilization of Pb(II) accumulated in biomass through phosphate-pretreated pyrolysis at low temperatures.
31  calcium overload group
(1 time)
Medicine
(1 time)
LDH (1 time)
LVDP (1 time)
Mel (1 time)
2017 [Role of melatonin in calcium overload-induced heart injury].
32  Calcium pantothenate
(1 time)
Pharmacology
(1 time)
CaPP (1 time)
1988 [The protective effect of pantothenic acid derivatives and changes in the system of acetyl CoA metabolism in acute ethanol poisoning].
33  calcium paradox
(1 time)
Biochemistry
(1 time)
MiCS (1 time)
2002 Regulation of mitochondrial contact sites in neonatal, juvenile and diabetic hearts.
34  calcium phosphate 2-D nanoflakes
(1 time)
Chemistry
(1 time)
CTS (1 time)
hAD-MSCs (1 time)
HNTs (1 time)
2019 Surface functionalization of halloysite nanotubes with supermagnetic iron oxide, chitosan and 2-D calcium-phosphate nanoflakes for synergistic osteoconduction enhancement of human adipose tissue-derived mesenchymal stem cells.
35  calcium phosphate apatite particles
(1 time)
Cell Biology
(1 time)
SBF (1 time)
2010 Heterotopic bone formation by nano-apatite containing poly(D,L-lactide) composites.
36  calcium phosphate coated ATT
(1 time)
Biomedical Research
(1 time)
ATT (1 time)
2013 Cellular performance comparison of biomimetic calcium phosphate coating and alkaline-treated titanium surface.
37  calcium phosphate composition
(1 time)
Medicine
(1 time)
NCCT (1 time)
SCR (1 time)
TUL (1 time)
2016 Calcium Phosphate Composition Affects Ureteroscopic Laser Lithotripsy.
38  calcium phosphate in the stone, a high AP
(1 time)
Urology
(1 time)
--- 1999 Factors influencing the course of calcium oxalate stone disease.
39  calcium phosphate nano-coated
(1 time)
Dentistry
(1 time)
Pg (1 time)
SLA (1 time)
2017 Erbium, Chromium:Yttrium-Scandium-Gallium-Garnet Laser Effectively Ablates Single-Species Biofilms on Titanium Disks Without Detectable Surface Damage.
40  calcium phosphate-based
(1 time)
Biomimetics
(1 time)
NR (1 time)
SBF (1 time)
2019 Towards the production of natural rubber-calcium phosphate hybrid for applications as bioactive coatings.
41  calcium salt of palm oil
(1 time)
Tropical Medicine
(1 time)
CaFL (2 times)
CaSF (1 time)
CSFA (1 time)
2017 Effects of different fat sources (saturated and unsaturated) on reproductive performance and biological indices of ewes during flushing period.
42  calcium-containing primer
(1 time)
Dentistry
(1 time)
SEB (1 time)
SEP (1 time)
2019 Evaluation of experimental calcium-containing primer in adhesive system on micro-tensile bond strength and acid resistance.
43  calculated from the AP
(1 time)
Urology
(1 time)
--- 1993 Circadian rhythms of urinary saturation levels of calcium oxalate and calcium phosphate in normal male individuals.
44  calculations of AP
(1 time)
Urolithiasis
(1 time)
APCaOx (1 time)
2013 A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time.
45  Californians with Prostate Cancer
(1 time)
Neoplasms
(1 time)
HRQoL (1 time)
2012 Prostate cancer survivorship: lessons from caring for the uninsured.
46  can accurately identify and grade prostatic adenocarcinoma
(1 time)
Neoplasms
(1 time)
RS (1 time)
2005 The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines.
47  CaN autoinhibitory peptide
(1 time)
Biochemistry
(1 time)
CaN (1 time)
CnA alpha (1 time)
CnA beta (1 time)
2002 Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit.
48  cancer cell line types
(1 time)
Chemistry Techniques, Analytical
(1 time)
FTIR-PAS (1 time)
2007 Discrimination of prostate cancer cells by reflection mode FTIR photoacoustic spectroscopy.
49  Cancer in Primary Care
(1 time)
Epidemiology
(1 time)
GP (1 time)
2014 Existing data sources for clinical epidemiology: Danish Cancer in Primary Care cohort.
50  Cancer of the pancreas
(1 time)
General Surgery
(1 time)
--- 2018 Cancer of the Pancreas-Actual 5, 10, and 20+Year Survival: The Lucky and Fortunate Few.
51  cancer of the renal pelvis
(1 time)
Nephrology
(1 time)
PhA (1 time)
RPN (1 time)
1986 Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer.
52  cancer patients
(1 time)
Urology
(1 time)
NAT2 (1 time)
2005 Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population.
53  cancer patients, including prostate cancer
(1 time)
Endocrinology
(1 time)
--- 2013 Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.
54  cancer types, among them prostate cancer
(1 time)
Biochemistry
(1 time)
--- 2019 The induction of Maspin expression by a glucosamine-derivative has an antiproliferative activity in prostate cancer cell lines.
55  cancers, and the association with human prostate cancer
(1 time)
Urology
(1 time)
CAB (1 time)
1998 Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade.
56  CaP alone
(1 time)
Spinal Diseases
(1 time)
AR (1 time)
BFs (1 time)
FE (1 time)
2014 Pedicle Screw Configuration for Thoracolumbar Burst Fracture Treatment: Short versus Long Posterior Fixation Constructs with and without Anterior Column Augmentation.
57  CaP chemically deposited
(1 time)
Biomimetics
(1 time)
ALP (1 time)
MAO (1 time)
Mg-Sr (1 time)
2019 Bone regeneration of hollow tubular magnesium‑strontium scaffolds in critical-size segmental defects: Effect of surface coatings.
58  CaP patients.Carcinoma of prostate
(1 time)
Chemistry Techniques, Analytical
(1 time)
--- 2013 Microfluidic chip coupled with modified paramagnetic particles for sarcosine isolation in urine.
59  CaP, an AP
(1 time)
Urology
(1 time)
CD (1 time)
2009 Studies on the role of calcium phosphate in the process of calcium oxalate crystal formation.
60  capable of improving prostate cancer
(1 time)
Neoplasms
(1 time)
PFS (1 time)
qPCR (1 time)
RNases (1 time)
2018 Expressional profiling and clinical relevance of RNase kappa in prostate cancer: a novel indicator of favorable progression-free survival.
61  carboplatin and paclitaxel
(1 time)
Medicine
(1 time)
FDG (1 time)
2013 Imaging of treatment response to the combination of carboplatin and paclitaxel in human ovarian cancer xenograft tumors in mice using FDG and FLT PET.
62  carcass price
(1 time)
Veterinary Medicine
(1 time)
LMA (1 time)
MS (1 time)
RT (1 time)
2007 Genetic relationships between growth and carcass traits and profitability in Japanese Brown cattle.
63  carcinogenesis and prostate cancer
(1 time)
Neoplasms
(1 time)
AR (1 time)
ROS (1 time)
SSAT (1 time)
2010 Androgen receptor requires JunD as a coactivator to switch on an oxidative stress generation pathway in prostate cancer cells.
64  care provided to men with localised prostate cancer
(1 time)
Medicine
(1 time)
DCC (1 time)
ICHOM (1 time)
LDCs (1 time)
2017 Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes.
65  case of androgen-independent prostate cancer
(1 time)
Urology
(1 time)
DC (1 time)
moDCs (1 time)
2005 Dendritic cells generated from patients with androgen-independent prostate cancer are not impaired in migration and T-cell stimulation.
66  cases of adenocarcinoma of prostate
(1 time)
Urology
(1 time)
BPH (1 time)
1993 Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study.
67  cell proliferation and the development of prostate cancer
(1 time)
Urology
(1 time)
CK (1 time)
HDAC1 (1 time)
HR (1 time)
2004 Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer.
68  cell proliferation, has been implicated in prostate cancer
(1 time)
Allergy and Immunology
(1 time)
MIF (1 time)
2007 Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence.
69  cells and in vitro typing cell cultures of prostate cancer
(1 time)
Neoplasms
(1 time)
--- 2002 p63 expression profile in normal and malignant prostate epithelial cells.
70  cells and metastases of prostate carcinoma
(1 time)
Urology
(1 time)
GS (1 time)
PET/CT (1 time)
PET/MRI (1 time)
2019 The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.
71  cells in the bone marrow of patients with prostate cancer
(1 time)
Neoplasms
(1 time)
--- 2000 Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.
72  cells, and AR expression is more variable in prostate cancer
(1 time)
Endocrinology
(1 time)
AR (1 time)
BPH (1 time)
2008 A role for the androgen-receptor in clinically localized and advanced prostate cancer.
73  cellular proliferation occurs in prostate cancer
(1 time)
Biochemistry
(1 time)
--- 2000 Characterization of calcium release-activated apoptosis of LNCaP prostate cancer cells.
74  cellular proteins in prostate cancer
(1 time)
Urology
(1 time)
--- 2007 HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.
75  change appears to be
(1 time)
General Surgery
(1 time)
CaT (1 time)
1988 The role of pH in altering serum ionized calcium concentration.
76  character and ability to monitor prostate cancer
(1 time)
Neoplasms
(1 time)
AMACR (1 time)
AUC (1 time)
EZH2 (1 time)
2011 Quadriplex model enhances urine-based detection of prostate cancer.
77  characteristic prostatic intraepithelial neoplasia or even prostatic cancer
(1 time)
Medicine
(1 time)
--- 2006 A mouse prostate cancer model induced by Hedgehog overexpression.
78  characterize prostate cancer
(1 time)
Urology
(1 time)
CI (1 time)
OR (1 time)
2007 Prostate cancer in the Baby Boomer generation: results from CaPSURE.
79  charges, and mortality in patients with prostate cancer
(1 time)
Neoplasms
(1 time)
EAPC (1 time)
NIS (1 time)
OR (1 time)
2015 The burden of skeletal-related events in patients with prostate cancer and bone metastasis.
80  chemokine axis is activated in prostate cancer
(1 time)
Metabolism
(1 time)
SDF-1 (1 time)
2005 Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
81  chemopreventive agents against prostate cancer
(1 time)
Science
(1 time)
GU (1 time)
PCNA (1 time)
2001 Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols.
82  chemotherapeutic and/or endocrine treatments for adenocarcinoma of the prostate
(1 time)
Neoplasms
(1 time)
FITC (1 time)
IgG (1 time)
PAcP (1 time)
1998 Immunocytochemical localization of an immunoconjugate (antibody IgG against prostatic acid phosphatase conjugated to 5-fluoro-2'-deoxyuridine) in human prostate tumors.
83  chemotherapeutic drugs against metastatic hormone-refractory prostate cancer
(1 time)
Antineoplastic Agents
(1 time)
Mr (1 time)
2003 An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis.
84  Chemotherapy in prostate cancer
(1 time)
Neoplasms
(1 time)
AR (1 time)
2007 Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer.
85  chemotherapy to treat prostate cancer
(1 time)
Neoplasms
(1 time)
CRPC (1 time)
2012 Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
86  chromosomal abnormalities in prostate cancer
(1 time)
Neoplasms
(1 time)
--- 2010 Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence.
87  citrate and for AP
(1 time)
Urology
(1 time)
--- 2012 Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.
88  clinical performance evaluation of a novel prostate cancer
(1 time)
Urology
(1 time)
PSA/SIA (1 time)
ROC (1 time)
2011 Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples.
89  clinical progression in prostate cancer
(1 time)
Neoplasms
(1 time)
AA (1 time)
EphA2 (1 time)
FAK (1 time)
2012 Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.
90  clinically localized prostate cancer
(1 time)
Urology
(1 time)
--- 2003 Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases.
91  clinically significant prostate adenocarcinoma
(1 time)
Reproductive Medicine
(1 time)
COMT (1 time)
ER (1 time)
NAT (1 time)
2010 Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.
92  clinically-significant prostate cancer
(1 time)
Urology
(1 time)
PSA (1 time)
2019 Use of MRI-Guided Biopsy for Selection and Follow-up of Men Undergoing Hemi-gland Cryoablation of Prostate Cancer.
93  coffee and prostate cancer
(1 time)
Neoplasms
(1 time)
AA (1 time)
CA (1 time)
PCaP (1 time)
2012 Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study.
94  cohorts, and in men with prostate cancer
(1 time)
Urology
(1 time)
AUC (1 time)
BMI (1 time)
DRE (1 time)
2014 The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy.
95  collected following prostate massage of men positive
(1 time)
Molecular Biology
(1 time)
MMP (1 time)
NGAL (1 time)
2017 Matrix metalloproteinase and heparin-stimulated serine proteinase activities in post-prostate massage urine of men with prostate cancer.
96  combining (a) multi-parametric MRI with spectroscopy for prostate cancer
(1 time)
BEC (1 time)
CE (1 time)
GEC (1 time)
2011 MULTI-MODAL DATA FUSION SCHEMES FOR INTEGRATED CLASSIFICATION OF IMAGING AND NON-IMAGING BIOMEDICAL DATA.
97  common and disabling consequence of prostate cancer
(1 time)
Medicine
(1 time)
PBMC (1 time)
2008 Osteoclasts are active in bone forming metastases of prostate cancer patients.
98  common and validated prostate cancer
(1 time)
AA (1 time)
CA (1 time)
ERG (1 time)
2014 Predominance of ERG-negative high-grade prostate cancers in African American men.
99  community-based prostate cancer
(1 time)
Education
(1 time)
HE (1 time)
SV (1 time)
2013 Prostate cancer survivors as community health educators: implications for informed decision making and cancer communication.
100  compare perceptions of prostate cancer
(1 time)
Public Health
(1 time)
CI (1 time)
OR (1 time)
PSA (1 time)
2014 Perceptions of prostate cancer fatalism and screening behavior between United States-born and Caribbean-born Black males.